{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T23:21:48Z","timestamp":1783812108348,"version":"3.55.0"},"reference-count":107,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2019.02235","type":"journal-article","created":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T04:16:10Z","timestamp":1569903370000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":39,"title":["Progress in Allogeneic Hematopoietic Cell Transplantation in Adult T-Cell Leukemia-Lymphoma"],"prefix":"10.3389","volume":"10","author":[{"given":"Atae","family":"Utsunomiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,10,1]]},"reference":[{"key":"B1","year":"2017","journal-title":"Provided by the Japanese Data Center for Hematopoietic Cell Transplantation (JDCHCT)."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.bbmt.2014.04.014","article-title":"Lenalidomide maintenance for high-risk multiple myeloma after allogeneic hematopoietic cell transplantation.","volume":"20","author":"Alsina","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1080\/10428194.2018.1427859","article-title":"Successful treatment of post-transplant relapsed adult T cell leukemia after cord blood transplantation with low-dose, short-term lenalidomide.","volume":"59","author":"Ando","year":"2018","journal-title":"Leuk Lymphoma."},{"key":"B4","first-page":"229","article-title":"Autologous bone marrow transplantation in a patient with lymphoma type adult T cell leukemia.","volume":"26","author":"Asou","year":"1985","journal-title":"Rinshoketsueki"},{"key":"B5","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/bf03006932","article-title":"Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP system.","volume":"86","author":"Atsuta","year":"2007","journal-title":"Int. J. Hematol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","article-title":"Defining the intensity of conditioning regimens: working definitions.","volume":"15","author":"Bacigalupo","year":"2009","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1038\/bmt.2014.143","article-title":"Outcome of patients with HTLV-1-associated adult T-cell leukemia\/lymphoma after SCT: a retrospective study by the EBMT LWP.","volume":"49","author":"Bazarbachi","year":"2014","journal-title":"Bone Marrow Transplant."},{"key":"B8","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/bmt.2013.219","article-title":"A prospective study of lenalidomide monotherapy for relapse after allo-SCT for multiple myeloma.","volume":"49","author":"Bensinger","year":"2014","journal-title":"Bone Marrow Transplant."},{"key":"B9","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1046\/j.1365-2141.1996.02338.x","article-title":"Successful treatment of HTLV-1-associated acute adult T-cell leukaemia lymphoma by allogeneic bone marrow transplantation.","volume":"94","author":"Borg","year":"1996","journal-title":"Br. J. Haematol."},{"key":"B10","article-title":"Unrelated bone marrow transplantation with reduced intensity conditioning regimen for elderly patients with adult T-cell leukemia\/lymphoma, feasibility study with two-year follow up data","author":"Choi","year":"2014","journal-title":"Proccedings of the 19th Congress of EHA, Abstract 1113"},{"key":"B11","article-title":"A feasibility study of cord blood cell transplantation for adult T cell leukemia\/lymphoma","author":"Choi","year":"2016","journal-title":"Proccedings of the 78th Annual Meeting of the Japanese Society of Hematology, Abstract OS-3-162"},{"key":"B12","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/bmt.2010.92","article-title":"Long-term outcomes after hematopoietic SCT for adult T-cell leukemia\/lymphoma: results of prospective trials.","volume":"46","author":"Choi","year":"2011","journal-title":"Bone Marrow Transplant."},{"key":"B13","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1200\/JCO.18.00501","article-title":"Revised adult T-cell leukemia-lymphoma international consensus meeting report.","volume":"37","author":"Cook","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/bmt.2015.265","article-title":"Early application of related stem-cell transplantation might improve clinical outcome in adult T-cell leukemia\/lymphoma.","volume":"51","author":"Fuji","year":"","journal-title":"Bone Marrow Transplant."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1200\/JCO.2016.67.8250","article-title":"Pretransplantation anti-CCR4 antibody mogamulizumab against adult T-cell leukemia\/lymphoma is associated with significantly increased risks of severe and corticosteroid-refractory graft-versus-host disease, nonrelapse mortality, and overall mortality.","volume":"34","author":"Fuji","year":"","journal-title":"J. Clin. Oncol."},{"key":"B16","first-page":"1","article-title":"Pre- and posttransplant use of mogamulizumab in patients with aggressive adult T-cell leukemia-lymphoma: a statement from key opinion leaders in Japan.","volume":"1","author":"Fuji","year":"","journal-title":"Adv. Cell Gene Ther."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.184564","article-title":"Outcomes of patients with relapsed aggressive adult T-cell leukemia-lymphoma: clinical effectiveness of anti-CCR4 antibody and allogeneic hematopoietic stem cell transplantation.","volume":"103","author":"Fuji","year":"","journal-title":"Haematologica"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.3324\/haematol.2017.164996","article-title":"Development of a modified prognostic index of patients with aggressive adult T-cell leukemia-lymphoma aged 70 years or younger: a possible risk-adapted management strategies including allogeneic transplantation.","volume":"102","author":"Fuji","year":"2017","journal-title":"Haematologica"},{"key":"B19","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s12185-013-1307-y","article-title":"Feasibility of cord blood transplantation in chemosensitive adult T-cell leukemia\/lymphoma: a retrospective analysis of the Nagasaki Transplantation network.","volume":"97","author":"Fukushima","year":"2013","journal-title":"Int. J. Hematol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/sj.leu.2403682","article-title":"Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia\/lymphoma.","volume":"19","author":"Fukushima","year":"2005","journal-title":"Leukemia"},{"key":"B21","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","article-title":"Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research.","volume":"15","author":"Giralt","year":"2009","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B22","doi-asserted-by":"publisher","first-page":"4715","DOI":"10.1002\/cncr.24531","article-title":"Risk score for outcome after allogeneic hematopoietic stem cell transplantation.","volume":"115","author":"Gratwohl","year":"2009","journal-title":"Cancer"},{"key":"B23","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1158\/0008-5472.can-03-1452","article-title":"Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell tranplantation.","volume":"64","author":"Harashima","year":"2004","journal-title":"Cancer Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1182\/blood-2009-10-247510","article-title":"Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study.","volume":"116","author":"Hishizawa","year":"2010","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reaction after bone marrow transplantation.","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1200\/jco.2016.67.7732","article-title":"Multicenter phase II study of lenalidomide in relapsed or recurrent adult T-cell leukemia\/lymphoma: ATLL-002.","volume":"34","author":"Ishida","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/j.bbmt.2013.09.014","article-title":"Impact of graft-versus-host disease on allogeneic hematopoietic cell transplantation for adult T cell leukemia-lymphoma focusing on preconditioning regimens: nationwide retrospective study.","volume":"19","author":"Ishida","year":"2013","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1182\/blood-2012-03-414490","article-title":"Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: a nationwide retrospective study.","volume":"120","author":"Ishida","year":"","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1200\/jco.2011.37.3472","article-title":"Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter Phase II study.","volume":"30","author":"Ishida","year":"","journal-title":"J. Clin. Oncol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"7529","DOI":"10.1158\/1078-0432.ccr-04-0983","article-title":"The CC chemokine receptor 4 (CCR4b) as a novel specific molecular target for immunotherapy in adult T-cell leukemia\/lymphoma.","volume":"10","author":"Ishida","year":"","journal-title":"Clin. Cancer Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"5494","DOI":"10.1158\/1078-0432.ccr-04-0371","article-title":"CXC chemokine receptor 3 and CC chemokine receptor 4 expression in T-cell and NK-cell lymphomas with special reference to clinicopathological significance for peripheral T-cell lymphoma, unspecified.","volume":"10","author":"Ishida","year":"","journal-title":"Clin. Cancer Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/bjh.15123","article-title":"Follow-up of a randomised phase II study of chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: impact on allogeneic haematopoietic stem cell transplantation.","volume":"184","author":"Ishida","year":"2019","journal-title":"Br. J. Haematol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/bjh.13338","article-title":"Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study.","volume":"169","author":"Ishida","year":"2015","journal-title":"Br. J. Haematol."},{"key":"B34","first-page":"3625","article-title":"Clinical significance of CCR4 expression in adult T-cell leukemia\/lymphoma: its close association with skin involvement and unfavorable outcome.","volume":"9","author":"Ishida","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1158\/1078-0432.CCR-09-2697","article-title":"Defucosylated humanized anti-CCR4 monoclonal antibody KW-0761 as a novel immunotherapeutic agent for adult T-cell leukemia\/lymphoma.","volume":"16","author":"Ishii","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e517","DOI":"10.1016\/S1470-2045(14)70202-5","article-title":"Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma.","volume":"15","author":"Ishitsuka","year":"2014","journal-title":"Lancet Oncol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1182\/blood-2012-07-444372","article-title":"Treatment of relapsed adult T-cell leukemia\/lymphoma after allogeneic hematopoietic stem cell transplantation: the Nagasaki Transplant Group experience.","volume":"121","author":"Itonaga","year":"2013","journal-title":"Blood"},{"key":"B38","doi-asserted-by":"publisher","first-page":"3612","DOI":"10.1182\/blood.v97.11.3612","article-title":"Cytogenetic analysis and clinical significance in adult T-cell leukemia\/lymphoma: a study of 50 cases from the human T-cell leukemia virus type-1 endemic area Nagasaki.","volume":"97","author":"Itoyama","year":"2001","journal-title":"Blood"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1182\/blood-2009-12-257410","article-title":"Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan.","volume":"116","author":"Iwanaga","year":"2010","journal-title":"Blood"},{"key":"B40","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1046\/j.1365-2141.2003.04054.x","article-title":"Allogeneic haematopoietic stem cell transplantation for the treatment of adult T-cell leukaemia\/lymphoma.","volume":"120","author":"Kami","year":"2003","journal-title":"Br. J. Haematol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1182\/blood-2011-07-368233","article-title":"Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study.","volume":"119","author":"Kanda","year":"2012","journal-title":"Blood"},{"key":"B42","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.bbmt.2009.11.011","article-title":"Nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome.","volume":"16","author":"Kasamon","year":"2010","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B43","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1182\/blood-2017-01-761874","article-title":"Prognostic relevance of integrated genetic profiling in adult T-cell leukemia\/lymphoma.","volume":"131","author":"Kataoka","year":"2018","journal-title":"Blood"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T cell leukemia\/lymphoma.","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat. Genet."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1016\/j.bbmt.2014.08.012","article-title":"Treatment of adult T-cell leukemia\/lymphoma with cord blood transplantation: a Japanese nationwide retrospective survey.","volume":"20","author":"Kato","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1200\/JCO.2011.38.2101","article-title":"Prognostic index for acute- and lymphoma-type adult T-cell leukemia\/lymphoma.","volume":"30","author":"Katsuya","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/s0140-6736(05)60077-3","article-title":"Eradication of human T-lymphotropic virus type 1 by allogeneic bone-marrow transplantation.","volume":"352","author":"Kawa","year":"1998","journal-title":"Lancet"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1016\/j.bbmt.2017.07.027","article-title":"Clinical practice recommendations on indication and timing of hematopoietic cell transplantation in mature T cell and NK\/T cell lymphomas: an international collaborative effort on behalf of the guidelines committee of the American Society for Blood and Marrow Transplantation.","volume":"23","author":"Kharfan-Dabaja","year":"2017","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B49","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3109\/10428190109099347","article-title":"Successful bone marrow transplantation for adult T-cell leukemia from a donor with oligoclonal proliferation of T-cells infected with human T-cell lymphotropic virus.","volume":"42","author":"Kishi","year":"2001","journal-title":"Leuk. Lymphoma"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1182\/blood-2011-04-348292","article-title":"Lenalidomide maintenance after nonmyeloablative allogeneic stem cell transplantation in multiple myeloma is not feasible: results of the HOVON 76 Trial.","volume":"118","author":"Kneppers","year":"2011","journal-title":"Blood"},{"key":"B51","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1182\/blood.V76.10.2065.2065","article-title":"Expression of P-glycoprotein in adult T-cell leukemia cells.","volume":"76","author":"Kuwazuru","year":"1990","journal-title":"Blood"},{"key":"B52","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1365-2141.1994.tb05040.x","article-title":"Infection of donor lymphocytes with human T lymphotropic virus type 1 (HTLV-I) following allogeneic bone marrow transplantation for HTLV-I positive adult T-cell leukaemia.","volume":"88","author":"Ljungman","year":"1994","journal-title":"Br. J. Haematol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B54","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/ajh.20349","article-title":"Donor cell derived myeloid leukemia after allogeneic cord blood transplantation in a patient with adult T-cell lymphoma.","volume":"79","author":"Matsunaga","year":"2005","journal-title":"Am. J. Hematol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/(sici)1096-8652(199906)61:2<144::aid-ajh13>3.0.co;2-6","article-title":"Spontaneous regression associated with apoptosis in a patient with acute-type adult T-cell leukemia.","volume":"61","author":"Matsushita","year":"1999","journal-title":"Am. J. Hematol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1084\/jem.20140987","article-title":"Gain-of-function CCR4 mutations in adult T cell leukemia\/lymphoma.","volume":"211","author":"Nakagawa","year":"2014","journal-title":"J. Exp. Med."},{"key":"B57","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(11)60315-2","article-title":"Donor-derived adult T-cell leukemia.","volume":"377","author":"Nakamizo","year":"2011","journal-title":"Lancet"},{"key":"B58","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s12185-012-1177-8","article-title":"Unrelated cord blood transplantation for patients with adult T-cell leukemia\/lymphoma: experience at a single institute.","volume":"96","author":"Nakamura","year":"2012","journal-title":"Int. J. Hematol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1038\/bmt.2014.204","article-title":"High incidence of CMV infection in adult T-cell leukemia\/lymphoma patients after allogeneic hematopoietic stem cell transplantation.","volume":"49","author":"Nakano","year":"2014","journal-title":"Bone Marrow Transplant."},{"key":"B60","article-title":"Impact of chromosomal abnormality in ATL patients who received allogeneic hematopoietic transplantation. An analysis on behave of JSHCT-ATL-WG","author":"Nakano","year":"2018","journal-title":"Proccedings of the 44th Annual Meeting of the European Society for Blood and Marrow (EBMT), OS1-5"},{"key":"B61","doi-asserted-by":"publisher","first-page":"940","DOI":"10.4049\/jimmunol.1301952","article-title":"HTLV-1 bZIP factor-specific CD4 T cell responses in adult T cell leukemia\/lymphoma patients after allogeneic hematopoietic stem cell transplantation.","volume":"192","author":"Narita","year":"2014","journal-title":"J. Immunol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1158\/0008-5472.can-03-2068","article-title":"Defucosylated chimeric anti-CC chemokine receptor 4 IgG1 with enhanced antibody-dependent cellular cytotoxicity shows potent therapeutic activity to T cell leukemia and lymphoma.","volume":"64","author":"Niwa","year":"2004","journal-title":"Cancer Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1111\/cas.13398","article-title":"Epidemiological and clinical features of adult T-cell leukemia-lymphoma in Japan, 2010-2011: a nationwide survey.","volume":"108","author":"Nosaka","year":"2017","journal-title":"Cancer Sci."},{"key":"B64","first-page":"203","article-title":"Allogenic bone marrow transplantation as a treatment for adult T-cell leukemia.","volume":"69","author":"Obama","year":"1999","journal-title":"Int. J. Hematol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/bmt.2012.121","article-title":"Foscarnet against human herpesvirus (HHV)-6 reactivation after allo-SCT: breakthrough HHV-6 encephalitis following antiviral prophylaxis.","volume":"48","author":"Ogata","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"B66","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/sj.bmt.1705907","article-title":"Plasama HHV-6 viral load-guided preemptive therapy against HHV-6 encephalopathy after allogeneic stem cell transplantation: a prospective evaluation.","volume":"41","author":"Ogata","year":"2008","journal-title":"Bone Marrow Transplant."},{"key":"B67","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/jmv.22013","article-title":"High incidence of cytomegalovirus, human herpesvirus-6, and Epstein-Barr virus reactivation in patients receiving cytotoxic chemotherapy for adult T cell leukemia.","volume":"83","author":"Ogata","year":"2011","journal-title":"J. Med. Virol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.bbmt.2018.02.008","article-title":"Effects of prophylactic foscarnet on human herpesvirus-6 reactivation and encephalitis in cord blood transplant recipients: a prospective multicenter trial with an historical control group.","volume":"24","author":"Ogata","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.bbmt.2006.06.007","article-title":"Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.","volume":"12","author":"Ogawa","year":"2006","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B70","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.1016\/S2352-3026(15)00284-7","article-title":"Lenalidomide in relapsed adult T-cell leukaemia-lymphoma or peripheral T-cell lymphoma (ATLL-001): a phase 1, multicentre, dose-escalation study.","volume":"3","author":"Ogura","year":"2016","journal-title":"Lancet Haematol."},{"key":"B71","first-page":"3120","article-title":"Prognostic significance of multidrug resistance protein in adult T-cell leukemia.","volume":"3120","author":"Ohno","year":"","journal-title":"Clin. Cancer Res."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1182\/blood.v98.4.1160","article-title":"Expression of functional lung resistance-related protein predicts poor outcome in adult T-cell leukemia.","volume":"98","author":"Ohno","year":"","journal-title":"Blood"},{"key":"B73","doi-asserted-by":"publisher","first-page":"4143","DOI":"10.1182\/blood-2004-11-4193","article-title":"Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia\/lymphoma.","volume":"105","author":"Okamura","year":"2005","journal-title":"Blood"},{"key":"B74","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1182\/blood-2018-02-835991","article-title":"CCR4 mutations associated with superior outcome of adult T-cell leukemia\/lymphoma under mogamulizumab treatment.","volume":"132","author":"Sakamoto","year":"2018","journal-title":"Blood"},{"key":"B75","doi-asserted-by":"crossref","first-page":"E143","DOI":"10.1002\/ajh.25438","article-title":"Cytomegalovirus reactivation is associated with increased mortality more than 100 days after allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia\/lymphoma.","volume":"94","author":"Sawayama","year":"2019","journal-title":"Am. J. Hematol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.bbmt.2014.02.014","article-title":"High level of serum soluble interleukin-2 receptor at transplantation predicts poor outcome of allogeneic stem cell transplantation for adult T cell leukemia.","volume":"20","author":"Shigematsu","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B77","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/1097-0142(19930801)72:3<735::aid-cncr2820720317>3.0.co;2-o","article-title":"Spontaneous regression in adult T-cell leukemia\/lymphoma.","volume":"72","author":"Shimamoto","year":"1993","journal-title":"Cancer"},{"key":"B78","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the lymphoma study group (1984-87).","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br. J. Haematol"},{"key":"B79","first-page":"221","article-title":"Chemotherapy of ATL","author":"Shimoyama","year":"1994","journal-title":"Adult T-Cell Leukemia"},{"key":"B80","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","article-title":"Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases.","volume":"91","author":"Slavin","year":"1998","journal-title":"Blood"},{"key":"B81","first-page":"441","article-title":"Treatment of adult T cell leukemia with mega-dose cyclophosphamide and total body irradiation followed by allogeneic bone marrow transplantation.","volume":"2","author":"Sobue","year":"1987","journal-title":"Bone Marrow Transplant."},{"key":"B82","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"B83","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/bjh.13302","article-title":"Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia\/lymphoma in a pilot study.","volume":"169","author":"Suehiro","year":"2015","journal-title":"Br. J. Haematol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.bbmt.2016.05.017","article-title":"Mogamulizumab treatment prior to allogeneic hematopoietic stem cell transplantation induces severe acute graft-versus-host disease.","volume":"22","author":"Sugio","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/j.bbmt.2015.06.008","article-title":"HLA-haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide after busulfan-containing reduced-intensity conditioning.","volume":"21","author":"Sugita","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B86","article-title":"Donor cell-derived Burkitt lymphoma after peripheral blood stem cell transplantation for ATL","author":"Takeuchi","year":"2015","journal-title":"Proceedings of the The 37th Annual Meeting of the Japan Society for Hematopoietic Cell Transplantation, Abstract P8-3"},{"key":"B87","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3109\/10428190009053558","article-title":"Spontaneous remission in acute type adult T-cell leukemia\/lymphoma.","volume":"39","author":"Takezako","year":"2000","journal-title":"Leuk. Lymphoma"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1056\/nejmc053295","article-title":"Donor-derived T-cell leukemia after bone marrow transplantation.","volume":"354","author":"Tamaki","year":"2006","journal-title":"New Engl. J. Med."},{"key":"B89","first-page":"175","article-title":"Retrospective analysis of cord blood transplantation on 62 adult patients with advanced hematological malignancies.","volume":"97","author":"Tamura","year":"2006","journal-title":"Fukuoka. Igaku. Zasshi."},{"key":"B90","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.bbmt.2008.03.010","article-title":"Allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning for adult T cell leukemia\/lymphoma: impact of antithymocyte globulin on clinical outcome.","volume":"14","author":"Tanosaki","year":"2008","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B91","year":"2017","journal-title":"Hematopoietic Cell Transplantation in Japan. Annual Report of Nationwide Survey 2017."},{"key":"B92","article-title":"Improved outcome of adult T cell leukemia-lymphoma with umbilical cord blood transplantation","author":"Tokunaga","year":"2018","journal-title":"Proceedings of The 40th Annual Meeting of the Japan Society for Hematopoietic Cell Transplantation, O2-5-3(1)"},{"key":"B93","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/10428194.2016.1187270","article-title":"Newly identified poor prognostic factors for adult T-cell leukemia-lymphoma treated with allogeneic hematopoietic stem cell transplantation.","volume":"58","author":"Tokunaga","year":"2017","journal-title":"Leuk. Lymphoma."},{"key":"B94","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1200\/JCO.2008.18.2428","article-title":"Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting.","volume":"27","author":"Tsukasaki","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/sj.bmt.1701533","article-title":"Poor outcome of autologous stem cell transplantation for adult T cell leukemia\/lymphoma: a case report and review of the literature.","volume":"23","author":"Tsukasaki","year":"1999","journal-title":"Bone Marrow Transplant."},{"key":"B96","doi-asserted-by":"publisher","first-page":"5458","DOI":"10.1200\/jco.2007.11.9958","article-title":"VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: japan Clinical Oncology Group Study JCOG9801.","volume":"25","author":"Tsukasaki","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/978-4-431-56523-9_11","article-title":"Transplantation for aggressive adult T-cell leukemia\/lymphoma (ATL)","author":"Utsunomiya","year":"2017","journal-title":"Adult T-cell Leukemia\/Lymphoma"},{"key":"B98","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/cas.12617","article-title":"Recent advances in treatment of adult T-cell leukemia-lymphomas.","volume":"106","author":"Utsunomiya","year":"2015","journal-title":"Cancer Sci."},{"key":"B99","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/sj.bmt.1702731","article-title":"Improved outcome of adult T cell leukemia\/lymphoma with allogeneic hematopoietic stem cell transplantation.","volume":"27","author":"Utsunomiya","year":"2001","journal-title":"Bone Marrow Transplant."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/j.bbmt.2012.06.014","article-title":"Graft-versus-host disease induced graft-versus-leukemia effect: greater impact on relapse and disease-free survival after reduced intensity conditioning.","volume":"18","author":"Weisdorf","year":"2012","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B101","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.bbmt.2010.10.010","article-title":"Donor cell leukemia: a review.","volume":"17","author":"Wiseman","year":"2011","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1200\/JCO.2009.25.3575","article-title":"Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma.","volume":"28","author":"Yamamoto","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/sj.leu.2404678","article-title":"Small number of HTLV-1-positive cells frequently remains during complete remission after allogeneic hematopoietic stem cell transplantation that are heterogeneous in origin among cases with adult T-cell leukemia\/lymphoma.","volume":"21","author":"Yamasaki","year":"2007","journal-title":"Leukemia"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/bmt.2008.39","article-title":"Graft-versus-adult T-cell leukemia\/lymphoma effect following allogeneic hematopoietic stem cell transplantation.","volume":"41","author":"Yonekura","year":"2008","journal-title":"Bone Marrow Transplant."},{"key":"B105","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/path.4699","article-title":"CCR4 frameshift mutation identifies a distinct group of adult T cell leukaemia\/lymphoma with poor prognosis.","volume":"238","author":"Yoshida","year":"2016","journal-title":"J. Pathol."},{"key":"B106","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.bbmt.2017.11.005","article-title":"Risk assessment in adult T-cell leukemia\/lymphoma treated with allogeneic hematopoietic stem cell transplantation.","volume":"24","author":"Yoshimitsu","year":"","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1038\/s41409-018-0400-5","article-title":"A retrospective analysis of haplo-identical HLA-mismatch hematopoietic transplantation without posttransplantation cyclophosphamide for GVHD prophylaxis in patients with adult T-cell leukemia-lymphoma.","volume":"54","author":"Yoshimitsu","year":"","journal-title":"Bone Marrow Transplant."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2019.02235\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,8]],"date-time":"2019-12-08T12:34:45Z","timestamp":1575808485000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2019.02235\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,1]]},"references-count":107,"alternative-id":["10.3389\/fmicb.2019.02235"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2019.02235","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,1]]},"article-number":"2235"}}